 | • レポートコード：MRC308GR11571 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の甲状腺機能亢進症治療薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の甲状腺機能亢進症治療薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 甲状腺機能亢進症治療薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
甲状腺機能亢進症治療薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・メチマゾール、プロピルチオウラシル、その他
用途別セグメント
・病院、診療所、その他
主要な市場プレーヤー
・Merck、Herbrand PharmaChemicals、Shanghai Zhaohui Pharmaceutical、Beijing Yanjing Pharmaceutical、Jinghua Pharmaceutical Group、Guangzhou Kanghe Pharmaceutical、Zigong Honghe Pharmaceutical、Guangdong Huanan Pharmaceutical、Zibo Wankang Pharmaceutical Chemical、Qilu Pharmaceutical
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、甲状腺機能亢進症治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な甲状腺機能亢進症治療薬メーカーの企業概要、2019年～2022年までの甲状腺機能亢進症治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な甲状腺機能亢進症治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別甲状腺機能亢進症治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの甲状腺機能亢進症治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での甲状腺機能亢進症治療薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および甲状腺機能亢進症治療薬の産業チェーンを掲載しています。
・第14、15章では、甲状腺機能亢進症治療薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 甲状腺機能亢進症治療薬の概要
– 種類別分析（2018年vs2022年vs2029年）：メチマゾール、プロピルチオウラシル、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他
– 世界の甲状腺機能亢進症治療薬市場規模・予測
– 世界の甲状腺機能亢進症治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Merck、Herbrand PharmaChemicals、Shanghai Zhaohui Pharmaceutical、Beijing Yanjing Pharmaceutical、Jinghua Pharmaceutical Group、Guangzhou Kanghe Pharmaceutical、Zigong Honghe Pharmaceutical、Guangdong Huanan Pharmaceutical、Zibo Wankang Pharmaceutical Chemical、Qilu Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：メチマゾール、プロピルチオウラシル、その他
・用途別分析2018年-2029年：病院、診療所、その他
・甲状腺機能亢進症治療薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・甲状腺機能亢進症治療薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・甲状腺機能亢進症治療薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・甲状腺機能亢進症治療薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・甲状腺機能亢進症治療薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Hyperthyroidism Medications
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Hyperthyroidism Medications Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Methimazole
1.3.3 Propylthiouracil
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Hyperthyroidism Medications Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Hyperthyroidism Medications Market Size & Forecast
1.5.1 Global Hyperthyroidism Medications Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Hyperthyroidism Medications Sales Quantity (2018-2029)
1.5.3 Global Hyperthyroidism Medications Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Hyperthyroidism Medications Product and Services
2.1.4 Merck Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Herbrand PharmaChemicals
2.2.1 Herbrand PharmaChemicals Details
2.2.2 Herbrand PharmaChemicals Major Business
2.2.3 Herbrand PharmaChemicals Hyperthyroidism Medications Product and Services
2.2.4 Herbrand PharmaChemicals Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Herbrand PharmaChemicals Recent Developments/Updates
2.3 Shanghai Zhaohui Pharmaceutical
2.3.1 Shanghai Zhaohui Pharmaceutical Details
2.3.2 Shanghai Zhaohui Pharmaceutical Major Business
2.3.3 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Product and Services
2.3.4 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
2.4 Beijing Yanjing Pharmaceutical
2.4.1 Beijing Yanjing Pharmaceutical Details
2.4.2 Beijing Yanjing Pharmaceutical Major Business
2.4.3 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Product and Services
2.4.4 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Beijing Yanjing Pharmaceutical Recent Developments/Updates
2.5 Jinghua Pharmaceutical Group
2.5.1 Jinghua Pharmaceutical Group Details
2.5.2 Jinghua Pharmaceutical Group Major Business
2.5.3 Jinghua Pharmaceutical Group Hyperthyroidism Medications Product and Services
2.5.4 Jinghua Pharmaceutical Group Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Jinghua Pharmaceutical Group Recent Developments/Updates
2.6 Guangzhou Kanghe Pharmaceutical
2.6.1 Guangzhou Kanghe Pharmaceutical Details
2.6.2 Guangzhou Kanghe Pharmaceutical Major Business
2.6.3 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Product and Services
2.6.4 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
2.7 Zigong Honghe Pharmaceutical
2.7.1 Zigong Honghe Pharmaceutical Details
2.7.2 Zigong Honghe Pharmaceutical Major Business
2.7.3 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Product and Services
2.7.4 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Zigong Honghe Pharmaceutical Recent Developments/Updates
2.8 Guangdong Huanan Pharmaceutical
2.8.1 Guangdong Huanan Pharmaceutical Details
2.8.2 Guangdong Huanan Pharmaceutical Major Business
2.8.3 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Product and Services
2.8.4 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Guangdong Huanan Pharmaceutical Recent Developments/Updates
2.9 Zibo Wankang Pharmaceutical Chemical
2.9.1 Zibo Wankang Pharmaceutical Chemical Details
2.9.2 Zibo Wankang Pharmaceutical Chemical Major Business
2.9.3 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Product and Services
2.9.4 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
2.10 Qilu Pharmaceutical
2.10.1 Qilu Pharmaceutical Details
2.10.2 Qilu Pharmaceutical Major Business
2.10.3 Qilu Pharmaceutical Hyperthyroidism Medications Product and Services
2.10.4 Qilu Pharmaceutical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Qilu Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Hyperthyroidism Medications by Manufacturer
3.1 Global Hyperthyroidism Medications Sales Quantity by Manufacturer (2018-2023)
3.2 Global Hyperthyroidism Medications Revenue by Manufacturer (2018-2023)
3.3 Global Hyperthyroidism Medications Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Hyperthyroidism Medications by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Hyperthyroidism Medications Manufacturer Market Share in 2022
3.4.2 Top 6 Hyperthyroidism Medications Manufacturer Market Share in 2022
3.5 Hyperthyroidism Medications Market: Overall Company Footprint Analysis
3.5.1 Hyperthyroidism Medications Market: Region Footprint
3.5.2 Hyperthyroidism Medications Market: Company Product Type Footprint
3.5.3 Hyperthyroidism Medications Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Hyperthyroidism Medications Market Size by Region
4.1.1 Global Hyperthyroidism Medications Sales Quantity by Region (2018-2029)
4.1.2 Global Hyperthyroidism Medications Consumption Value by Region (2018-2029)
4.1.3 Global Hyperthyroidism Medications Average Price by Region (2018-2029)
4.2 North America Hyperthyroidism Medications Consumption Value (2018-2029)
4.3 Europe Hyperthyroidism Medications Consumption Value (2018-2029)
4.4 Asia-Pacific Hyperthyroidism Medications Consumption Value (2018-2029)
4.5 South America Hyperthyroidism Medications Consumption Value (2018-2029)
4.6 Middle East and Africa Hyperthyroidism Medications Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Hyperthyroidism Medications Sales Quantity by Type (2018-2029)
5.2 Global Hyperthyroidism Medications Consumption Value by Type (2018-2029)
5.3 Global Hyperthyroidism Medications Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Hyperthyroidism Medications Sales Quantity by Application (2018-2029)
6.2 Global Hyperthyroidism Medications Consumption Value by Application (2018-2029)
6.3 Global Hyperthyroidism Medications Average Price by Application (2018-2029)
7 North America
7.1 North America Hyperthyroidism Medications Sales Quantity by Type (2018-2029)
7.2 North America Hyperthyroidism Medications Sales Quantity by Application (2018-2029)
7.3 North America Hyperthyroidism Medications Market Size by Country
7.3.1 North America Hyperthyroidism Medications Sales Quantity by Country (2018-2029)
7.3.2 North America Hyperthyroidism Medications Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Hyperthyroidism Medications Sales Quantity by Type (2018-2029)
8.2 Europe Hyperthyroidism Medications Sales Quantity by Application (2018-2029)
8.3 Europe Hyperthyroidism Medications Market Size by Country
8.3.1 Europe Hyperthyroidism Medications Sales Quantity by Country (2018-2029)
8.3.2 Europe Hyperthyroidism Medications Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Hyperthyroidism Medications Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Hyperthyroidism Medications Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Hyperthyroidism Medications Market Size by Region
9.3.1 Asia-Pacific Hyperthyroidism Medications Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Hyperthyroidism Medications Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Hyperthyroidism Medications Sales Quantity by Type (2018-2029)
10.2 South America Hyperthyroidism Medications Sales Quantity by Application (2018-2029)
10.3 South America Hyperthyroidism Medications Market Size by Country
10.3.1 South America Hyperthyroidism Medications Sales Quantity by Country (2018-2029)
10.3.2 South America Hyperthyroidism Medications Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Hyperthyroidism Medications Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Hyperthyroidism Medications Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Hyperthyroidism Medications Market Size by Country
11.3.1 Middle East & Africa Hyperthyroidism Medications Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Hyperthyroidism Medications Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Hyperthyroidism Medications Market Drivers
12.2 Hyperthyroidism Medications Market Restraints
12.3 Hyperthyroidism Medications Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Hyperthyroidism Medications and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hyperthyroidism Medications
13.3 Hyperthyroidism Medications Production Process
13.4 Hyperthyroidism Medications Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hyperthyroidism Medications Typical Distributors
14.3 Hyperthyroidism Medications Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Hyperthyroidism Medications Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hyperthyroidism Medications Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Hyperthyroidism Medications Product and Services
Table 6. Merck Hyperthyroidism Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Herbrand PharmaChemicals Basic Information, Manufacturing Base and Competitors
Table 9. Herbrand PharmaChemicals Major Business
Table 10. Herbrand PharmaChemicals Hyperthyroidism Medications Product and Services
Table 11. Herbrand PharmaChemicals Hyperthyroidism Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Herbrand PharmaChemicals Recent Developments/Updates
Table 13. Shanghai Zhaohui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Shanghai Zhaohui Pharmaceutical Major Business
Table 15. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Product and Services
Table 16. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
Table 18. Beijing Yanjing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Beijing Yanjing Pharmaceutical Major Business
Table 20. Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Product and Services
Table 21. Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Beijing Yanjing Pharmaceutical Recent Developments/Updates
Table 23. Jinghua Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 24. Jinghua Pharmaceutical Group Major Business
Table 25. Jinghua Pharmaceutical Group Hyperthyroidism Medications Product and Services
Table 26. Jinghua Pharmaceutical Group Hyperthyroidism Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Jinghua Pharmaceutical Group Recent Developments/Updates
Table 28. Guangzhou Kanghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Guangzhou Kanghe Pharmaceutical Major Business
Table 30. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Product and Services
Table 31. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
Table 33. Zigong Honghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Zigong Honghe Pharmaceutical Major Business
Table 35. Zigong Honghe Pharmaceutical Hyperthyroidism Medications Product and Services
Table 36. Zigong Honghe Pharmaceutical Hyperthyroidism Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Zigong Honghe Pharmaceutical Recent Developments/Updates
Table 38. Guangdong Huanan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Guangdong Huanan Pharmaceutical Major Business
Table 40. Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Product and Services
Table 41. Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Guangdong Huanan Pharmaceutical Recent Developments/Updates
Table 43. Zibo Wankang Pharmaceutical Chemical Basic Information, Manufacturing Base and Competitors
Table 44. Zibo Wankang Pharmaceutical Chemical Major Business
Table 45. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Product and Services
Table 46. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
Table 48. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Qilu Pharmaceutical Major Business
Table 50. Qilu Pharmaceutical Hyperthyroidism Medications Product and Services
Table 51. Qilu Pharmaceutical Hyperthyroidism Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Qilu Pharmaceutical Recent Developments/Updates
Table 53. Global Hyperthyroidism Medications Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Hyperthyroidism Medications Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Hyperthyroidism Medications Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Hyperthyroidism Medications, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Hyperthyroidism Medications Production Site of Key Manufacturer
Table 58. Hyperthyroidism Medications Market: Company Product Type Footprint
Table 59. Hyperthyroidism Medications Market: Company Product Application Footprint
Table 60. Hyperthyroidism Medications New Market Entrants and Barriers to Market Entry
Table 61. Hyperthyroidism Medications Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Hyperthyroidism Medications Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Hyperthyroidism Medications Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Hyperthyroidism Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Hyperthyroidism Medications Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Hyperthyroidism Medications Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Hyperthyroidism Medications Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Hyperthyroidism Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Hyperthyroidism Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Hyperthyroidism Medications Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Hyperthyroidism Medications Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Hyperthyroidism Medications Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Hyperthyroidism Medications Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Hyperthyroidism Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Hyperthyroidism Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Hyperthyroidism Medications Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Hyperthyroidism Medications Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Hyperthyroidism Medications Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Hyperthyroidism Medications Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Hyperthyroidism Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Hyperthyroidism Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Hyperthyroidism Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Hyperthyroidism Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Hyperthyroidism Medications Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Hyperthyroidism Medications Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Hyperthyroidism Medications Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Hyperthyroidism Medications Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Hyperthyroidism Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Hyperthyroidism Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Hyperthyroidism Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Hyperthyroidism Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Hyperthyroidism Medications Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Hyperthyroidism Medications Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Hyperthyroidism Medications Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Hyperthyroidism Medications Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Hyperthyroidism Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Hyperthyroidism Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Hyperthyroidism Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Hyperthyroidism Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Hyperthyroidism Medications Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Hyperthyroidism Medications Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Hyperthyroidism Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Hyperthyroidism Medications Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Hyperthyroidism Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Hyperthyroidism Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Hyperthyroidism Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Hyperthyroidism Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Hyperthyroidism Medications Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Hyperthyroidism Medications Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Hyperthyroidism Medications Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Hyperthyroidism Medications Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Hyperthyroidism Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Hyperthyroidism Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Hyperthyroidism Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Hyperthyroidism Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Hyperthyroidism Medications Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Hyperthyroidism Medications Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Hyperthyroidism Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Hyperthyroidism Medications Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Hyperthyroidism Medications Raw Material
Table 121. Key Manufacturers of Hyperthyroidism Medications Raw Materials
Table 122. Hyperthyroidism Medications Typical Distributors
Table 123. Hyperthyroidism Medications Typical Customers
List of Figures
Figure 1. Hyperthyroidism Medications Picture
Figure 2. Global Hyperthyroidism Medications Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hyperthyroidism Medications Consumption Value Market Share by Type in 2022
Figure 4. Methimazole Examples
Figure 5. Propylthiouracil Examples
Figure 6. Other Examples
Figure 7. Global Hyperthyroidism Medications Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Hyperthyroidism Medications Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Other Examples
Figure 12. Global Hyperthyroidism Medications Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Hyperthyroidism Medications Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Hyperthyroidism Medications Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Hyperthyroidism Medications Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Hyperthyroidism Medications Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Hyperthyroidism Medications Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Hyperthyroidism Medications by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Hyperthyroidism Medications Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Hyperthyroidism Medications Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Hyperthyroidism Medications Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Hyperthyroidism Medications Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Hyperthyroidism Medications Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Hyperthyroidism Medications Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Hyperthyroidism Medications Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Hyperthyroidism Medications Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Hyperthyroidism Medications Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Hyperthyroidism Medications Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Hyperthyroidism Medications Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Hyperthyroidism Medications Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Hyperthyroidism Medications Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Hyperthyroidism Medications Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Hyperthyroidism Medications Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Hyperthyroidism Medications Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Hyperthyroidism Medications Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Hyperthyroidism Medications Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Hyperthyroidism Medications Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Hyperthyroidism Medications Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Hyperthyroidism Medications Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Hyperthyroidism Medications Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Hyperthyroidism Medications Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Hyperthyroidism Medications Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Hyperthyroidism Medications Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Hyperthyroidism Medications Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Hyperthyroidism Medications Consumption Value Market Share by Region (2018-2029)
Figure 54. China Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Hyperthyroidism Medications Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Hyperthyroidism Medications Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Hyperthyroidism Medications Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Hyperthyroidism Medications Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Hyperthyroidism Medications Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Hyperthyroidism Medications Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Hyperthyroidism Medications Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Hyperthyroidism Medications Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Hyperthyroidism Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Hyperthyroidism Medications Market Drivers
Figure 75. Hyperthyroidism Medications Market Restraints
Figure 76. Hyperthyroidism Medications Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Hyperthyroidism Medications in 2022
Figure 79. Manufacturing Process Analysis of Hyperthyroidism Medications
Figure 80. Hyperthyroidism Medications Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source